We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Investing in Biotech Research to Dampen Patent Cliff Fall
Drugmakers Investing in Biotech Research to Dampen Patent Cliff Fall
New technology and anxiety over expiring patents have driven pharma to triple clinical development of large molecule and biologic drugs over the past decade, says an industry expert.